Craft

Chengdu Kanghua Biological Products

Stock Price

¥60.7

2024-10-29

Market Capitalization

¥7.9 B

2024-10-29

Revenue

¥1.2 B

FY, 2025

Chengdu Kanghua Biological Products Summary

Company Summary

Overview
Chengdu Kanghua Biological Products (成都康华生物制品股份有限公司) is a company specializing in the research, development, and production of biological products. It manufactures vaccines, including meningococcal and rabies vaccines, and provides related technical services. The company operates in the biotechnology and pharmaceutical sectors.
Type
Public
Status
Active
Founded
2004
HQ
Chengdu, CN | view all locations
Website
https://en.kangh.com/index.aspx
Cybersecurity rating
Sectors

LocationsView all

2 locations detected

  • Chengdu, Sichuan HQ

    China

    No. 182, Beijing Road, Economic and Technological Development Zone

  • Chengdu, Sichuan

    China

    No. 288, Haida Road, Wenjiang District

Chengdu Kanghua Biological Products Financials

Summary Financials

Revenue (Q1, 2026)
¥168.0M
Gross profit (Q1, 2026)
¥152.5M
Net income (Q1, 2026)
¥27.4M
Cash (Q1, 2026)
¥513.3M
EBIT (Q1, 2026)
¥28.7M
Enterprise value
$7.5B

Footer menu